Interruption of natalizumab therapy for multiple sclerosis
Authors:
- 31 May 2011
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 76 (22) , 1854-1855
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisNeurology, 2011
- Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies?Annals of Neurology, 2010
- Anti‐JC virus antibodies: Implications for PML Risk StratificationAnnals of Neurology, 2010
- The present efficacy of multiple sclerosis therapeuticsNeurology, 2009
- New cases of progressive multifocal leukoencephalopathy after treatment with natalizumabThe Lancet Neurology, 2009
- Immune surveillance in multiple sclerosis patients treated with natalizumabAnnals of Neurology, 2006